AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,993,000 | +1792.4% | 220,124 | +1328.7% | 0.00% | – |
| Q2 2020 | $211,000 | +54.0% | 15,407 | +61.2% | 0.00% | – |
| Q1 2020 | $137,000 | -20.3% | 9,558 | -6.1% | 0.00% | – |
| Q4 2019 | $172,000 | +109.8% | 10,179 | +91.4% | 0.00% | – |
| Q3 2019 | $82,000 | -89.2% | 5,317 | -83.6% | 0.00% | -100.0% |
| Q2 2019 | $761,000 | -21.2% | 32,448 | -4.9% | 0.00% | 0.0% |
| Q1 2019 | $966,000 | +183.3% | 34,106 | +201.8% | 0.00% | – |
| Q4 2018 | $341,000 | +278.9% | 11,300 | +338.0% | 0.00% | – |
| Q3 2018 | $90,000 | +2900.0% | 2,580 | +1964.0% | 0.00% | – |
| Q1 2018 | $3,000 | +50.0% | 125 | -3.1% | 0.00% | – |
| Q4 2017 | $2,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |